Seek­ing to treat obe­si­ty drug side ef­fect, Neu­ro­gas­trx re­leas­es da­ta on drug for GLP-1-as­so­ci­at­ed nau­sea, vom­it­ing

Neu­ro­gas­trx be­lieves its drug could treat one of the most trou­ble­some side ef­fects of one of the in­dus­try’s biggest block­busters.

On Wednes­day, the Boston-area biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER